Protocol Library
Each card lists peptide research notes — vial size, example research dose range, reconstitution example, frequency example, cycle length example, and risk level. All entries are educational. Not medical advice.
BPC-157
low riskCommonly researched for tendon, ligament, gut lining and wound repair contexts.
- Vial
- 5 mg
- Dose
- 200–500 mcg daily (research literature)
- Freq
- 1–2x daily (research example)
- Cycle
- 4–8 weeks (research example)
Cartalax
low riskCommonly researched for cartilage, connective-tissue and joint research models.
- Vial
- 20 mg
- Dose
- Research literature commonly references 100–200 mcg per research day.
- Freq
- Once daily in research scheduling examples.
- Cycle
- 10–20 days per research cycle, often repeated 2–3 times per year in published bioregulator protocols.
CJC-1295 (no DAC)
low riskResearched in growth hormone pulse research, often paired with GHRPs.
- Vial
- 2 mg
- Dose
- 100 mcg per use (research literature)
- Freq
- 1–3x daily (research example)
- Cycle
- 8–12 weeks (research example)
CJC-1295 with DAC
moderate riskResearched in studies of sustained GH/IGF-1 elevation.
- Vial
- 2 mg
- Dose
- 1–2 mg weekly (research literature)
- Freq
- 1–2x weekly (research example)
- Cycle
- 8–12 weeks (research example)
GHK-Cu
low riskResearched in dermal repair, hair follicle, and anti-aging contexts.
- Vial
- 50 mg
- Dose
- 1–2 mg per use (research literature)
- Freq
- Topical or subq (research example)
- Cycle
- 4–8 weeks (research example)
GHRP-2
moderate riskInvestigated for pulsatile growth hormone release via ghrelin receptor agonism.
- Vial
- 5 mg lyophilized vial
- Dose
- Commonly discussed research range: 100–300 mcg per administration.
- Freq
- 2–3x daily in research designs.
- Cycle
- 8–12 week educational example.
GHRP-6
moderate riskInvestigated for GH pulsatility and appetite signaling via ghrelin receptor agonism.
- Vial
- 5 mg lyophilized vial
- Dose
- Commonly discussed research range: 100–300 mcg per administration.
- Freq
- 2–3x daily in research designs.
- Cycle
- 8–12 week educational example.
GLOW Blend (BPC-157 + TB-500 + GHK-Cu)
moderate riskStudied as a combined research peptide profile for repair-related endpoints.
- Vial
- Blend vial (varies by source)
- Dose
- Educational research dose example only.
- Freq
- Daily or alternating-day research designs.
- Cycle
- 4–8 week educational example.
IGF-1 DES
high riskInvestigated for local IGF-1 receptor activity with reduced IGFBP binding.
- Vial
- 1 mg lyophilized vial
- Dose
- Commonly discussed research range: 50–100 mcg per site.
- Freq
- Site-specific in research designs.
- Cycle
- 4 week educational example.
IGF-1 LR3
high riskStudied for its role in IGF-1 pathway research, cellular growth signaling and muscle-research models.
- Vial
- 1 mg
- Dose
- Published research literature commonly cites 20–50 mcg per research day in cellular and animal study ranges.
- Freq
- Once daily in research scheduling examples.
- Cycle
- Short research cycles (commonly 4–6 weeks).
Ipamorelin
low riskResearched as a selective ghrelin receptor agonist in GH studies.
- Vial
- 5 mg
- Dose
- 100–300 mcg per use (research literature)
- Freq
- 1–3x daily (research example)
- Cycle
- 8–12 weeks (research example)
PEG-MGF
moderate riskInvestigated for myogenic precursor activation via MGF/IGF-1Ec splice variant pathway.
- Vial
- 2 mg lyophilized vial
- Dose
- Commonly discussed research range: 200–400 mcg per administration.
- Freq
- 2–3x weekly in research designs.
- Cycle
- 4–6 week educational example.
Sermorelin
low riskResearched as a GHRH analog in pituitary GH release studies.
- Vial
- 5 mg
- Dose
- 100–300 mcg per use (research literature)
- Freq
- Nightly (research example)
- Cycle
- 8–12 weeks (research example)
TB-500
moderate riskResearched in soft tissue, muscle, and vascular repair contexts.
- Vial
- 5 mg
- Dose
- 2–5 mg weekly (research literature)
- Freq
- 1–2x weekly (research example)
- Cycle
- 4–6 weeks (research example)
Looking for a research supplier?
Enhanced Performance is a separate research supply platform. Visiting or purchasing is optional and not required to use PepToolbox.
Disclosure: Enhanced Performance is a separate platform connected to the owner of this website. Purchasing is optional and not required to use this tool.